Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy. [electronic resource]
- Journal of viral hepatitis Nov 2008
- 790-6 p. digital
Publication Type: Journal Article
1365-2893
10.1111/j.1365-2893.2008.01038.x doi
Absorptiometry, Photon Adult Antiviral Agents--therapeutic use Bone Density--drug effects Bone and Bones--metabolism Collagen Type I--blood Female Follow-Up Studies Hepatitis C, Chronic--drug therapy Humans Interferon alpha-2 Interferon-alpha--therapeutic use Male Middle Aged Osteocalcin--blood Osteoporosis Prospective Studies Recombinant Proteins Ribavirin--therapeutic use